Suppr超能文献

[下尿路感染的单剂量疗法]

[Single-dose therapy of infections of the lower urinary tract].

作者信息

Krcméry S, Hromec J

机构信息

IV. interná klinika NsP Staré Mesto v Bratislave, Slovakia.

出版信息

Bratisl Lek Listy. 1995 Feb;96(2):104-7.

PMID:7633913
Abstract

The authors analyze two clinical studies in the frame of single-dose treatment of uncomplicated infection of the lower urinary tract. The first study deals with comparison of the effect of netilmicin, ciprofloxacine and aztreonam. The second study deals with pefloxacine and cefuroxim-axetil. As the results implied, both long-term and short-term effectiveness of therapy comparable with other verified regimes was accomplished in female patients who were not pregnant and irrespective of their age. It is necessary to respect the contraindications of therapy. Chemotherapeutics which are appropriate for single-dose therapy of uncomplicated infections of the lower urinary duct include quinolones (pefloxacine, ciprofloxacine), phosphomycin-trometamol, co-trimoxozole a netilmicin. The majority of oral beta-lactam antibiotics cannot be recommended for a single-dose therapy of uroinfections. The authors summarize the advantages of a single-dose therapy of uroinfections and analyze the criteria of significant bacteriuria.

摘要

作者们在单纯性下尿路感染单剂量治疗框架内分析了两项临床研究。第一项研究涉及奈替米星、环丙沙星和氨曲南疗效的比较。第二项研究涉及培氟沙星和头孢呋辛酯。结果表明,在非妊娠女性患者中,无论年龄大小,该疗法的长期和短期有效性均与其他已证实的治疗方案相当。必须遵守治疗的禁忌证。适用于单纯性下尿路导管感染单剂量治疗的化疗药物包括喹诺酮类(培氟沙星、环丙沙星)、磷霉素钙、复方新诺明和奈替米星。大多数口服β-内酰胺类抗生素不推荐用于尿路感染的单剂量治疗。作者总结了尿路感染单剂量治疗的优势,并分析了显著菌尿的标准。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验